- Apply and adapt frontier AI models to design biologics that push the limits on format, precision, and function.
- Partner closely with internal and external scientists and engineers to advance molecules toward their Target Product Profiles.
- Collaborate with AI research and engineering teams to improve core models and infrastructure for future discovery.
- Leverage modern AI dev tooling to move fast and stay focused on high-value work
- 4+ years of experience developing or applying AI in biology, chemistry, or physics; therapeutic experience is a plus.
- Experience collaborating with wet-lab teams or direct experience with biological experiments.
- Strong fluency in Python.
- Familiarity with HPC environments (e.g., Kubernetes, SLURM).
- Experience with deep learning frameworks like PyTorch.
- High agency and a track record of shipping quickly with quality
- A dry- and wet-lab team and platform that lets you generate and test high-impact therapeutic ideas in days or weeks, not months.
- The chance to shape the next generation of drugs, both through Nabla’s internal pipeline and in partnership with world-class Top-10 pharma partners.
- A team that deeply values technology and prioritizes technical excellence and rapid execution across AI and biology.
- Highly competitive salary, equity, and benefits package.
Skills Required
- 4+ years of experience in AI development in biology, chemistry, or physics
- Experience collaborating with wet-lab teams
- Strong fluency in Python
- Familiarity with HPC environments
- Experience with deep learning frameworks like PyTorch
What We Do
We develop AI and wet-lab technologies that enable the rational design of developable, selective, and functional drugs against previously undruggable targets. To maximize the patient impact of our platform, we collaborate with leading pharmaceutical companies, including AstraZeneca, Bristol Myers Squibb and Takeda, to expand their pipelines with high-quality drug candidates. If successful we could double the number of disease-relevant drug targets the industry advances for drug development. Since launching in 2021 we have raised $37 million with the backing of leading investors, including Radical Ventures, Khosla Ventures and Zetta Venture Partners. Our technical team is based in Cambridge, Massachusetts and continues to recruit top machine learning and synthetic biology talent. For more information check out the Careers section of our website at www.nabla.bio.
